FOXO4 research in Canada investigates the senolytic properties of this modified transcription factor peptide. FOXO4-DRI is a D-amino acid retroinverso (DRI) form of a FOXO4 peptide that disrupts the interaction between FOXO4 and p53 in senescent cells. Canadian aging biology researchers study FOXO4-DRI to understand how disrupting senescent cell survival mechanisms can be used experimentally to model senescent cell clearance.
What Are Senescent Cells?
Cellular senescence is a state in which cells permanently arrest their cell cycle but resist apoptosis. Senescent cells accumulate with age and secrete a pro-inflammatory senescence-associated secretory phenotype (SASP). Canadian aging researchers study senescent cell biology to understand how their accumulation contributes to tissue dysfunction and aging phenotypes in research models.
FOXO4 and p53 Interaction Research
In senescent cells, FOXO4 interacts with p53 and promotes its nuclear retention, protecting senescent cells from apoptosis. FOXO4-DRI competitively disrupts this interaction, allowing p53 to drive apoptosis in senescent cells. Canadian researchers study this mechanism as a model for targeted senescent cell elimination in aging biology research.
Sourcing FOXO4 in Canada
Research-grade FOXO4 peptide is available in Canada from EhBuddy Peptides. Lab-tested for purity. For laboratory research use only — not for human or veterinary consumption.
FOXO4 research represents one of the most exciting frontiers in Canadian cellular aging science, offering a targeted experimental tool for senescent cell biology.
